Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04142359 · ClinicalTrials.gov registry record
PK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14)
A clinical trial, sponsored by Altor BioScience.
- Terminated
- Registry status
- 1
- Enrollment target
NCT04142359 is a clinical trial that was terminated before completion, run by Altor BioScience. The registered enrollment target is 1 participants.
The verdict
NCT04142359 was terminated before completion, sponsored by Altor BioScience.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
Non-interventional PK sub-study of QUILT-3.032 (CA-ALT-803-01-16) and QUILT-2.005 (CA-ALT-803-01-14)
Interventions
- BIOLOGICAL BCG in Combination with N-803
- DRUG N-803 alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2019-12-09 |
| Est. Completion | 2020-04-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04142359
The ClinicalTrials.gov registry entry for NCT04142359 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Altor BioScience, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which BCG in Combination with N-803 is the first listed.
NCT04142359 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04142359 about?
NCT04142359 is a clinical study titled "PK Sub-Study of QUILT-3.032 (CA ALT-803-01-16) and of QUILT-2.005 (CA ALT-803-01-14)". Non-interventional PK sub-study of QUILT-3.032 (CA-ALT-803-01-16) and QUILT-2.005 (CA-ALT-803-01-14)
What is the current status of trial NCT04142359?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2019-12-09. Estimated completion is 2020-04-06.
What interventions are being tested in trial NCT04142359?
The interventions under investigation include: BCG in Combination with N-803 (BIOLOGICAL), N-803 alone (DRUG).
Who is sponsoring clinical trial NCT04142359?
This trial is sponsored by Altor BioScience, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.